|
Age [year, median (range)]
|
19.3 (19–20)
|
|
Male [n (%)]
|
63 (100)
|
|
Education [n (%)]
|
|
College or more
|
40 (63.5)
|
|
High school or less
|
23 (36.5)
|
|
Socioeconomic status [n (%)]
|
|
High
|
8 (12.7)
|
|
Middle
|
33 (52.4)
|
|
Low
|
22 (34.9)
|
|
Parental coresidence status [n (%)]
|
|
Both
|
54 (85.7)
|
|
One parent
|
8 (12.7)
|
|
None
|
1 (1.6)
|
|
Abnormal MPI results [n (%)]
|
20 (31.7)
|
|
mCSS (2–9, x ± s)
|
4.05 ± 1.58
|
|
NRS (0–10, x ± s)
|
6.25 ± 1.57
|
|
Pain duration (month, x ± s)
|
27.41 ± 2.67
|
|
CRPS type [n (%)]
|
|
I
|
49 (77.8)
|
|
II
|
14 (22.2)
|
|
Affected site [n (%)]
|
|
Upper extremity
|
18 (28.6)
|
|
Lower extremity
|
43 (68.3)
|
|
Multiple
|
2 (3.2)
|
|
Symptomatic presentation [n (%)]
|
|
Allodynia
|
45 (71.4)
|
|
Hyperalgesia
|
42 (66.7)
|
|
Temperature asymmetry
|
34 (54.0)
|
|
Skin color asymmetry
|
36 (57.1)
|
|
Sweating asymmetry
|
28 (44.4)
|
|
Asymmetric edema
|
26 (41.3)
|
|
Trophic changes
|
12 (19.0)
|
|
Motor dysfunction
|
21 (33.3)
|
|
Decreased active range of motion
|
8 (12.7)
|
|
Treatment [n (%)]
|
|
Physical or pharmacological therapy
|
21 (33.3)
|
|
Sympathetic nerve intervention
|
33 (52.4)
|
|
Spinal cord stimulation
|
9 (14.3)
|
